TerrAscend reports quarterly net loss on cannabis revenues of CA$14.6 million

TerrAscend, a Toronto-based vertically integrated marijuana company, reported revenues of 14.6 million Canadian dollars ($10.95 million) for the quarter ended March 31, 2019, with a net loss of CA$11.2 million.

The company did not report revenues for the comparable quarter in 2018. Its net loss for that period was CA$2.35 million.

During the quarter, TerrAscend acquired The Apothecarium, a San Francisco-based retailer, in a deal worth more than $118 million.

TerrAscend trades on the Canadian Securities Exchange under the ticker symbol TER.

More details on the company’s quarterly results can be found here.

One comment on “TerrAscend reports quarterly net loss on cannabis revenues of CA$14.6 million
  1. Maxcatski on

    I am confused. How can a legal Canadian company participate in the illegal cannabis market in the US? Health Canada does not allow illegal activities.

    And I am amazed how any company can lose $11MM on revenues of $14.6 and call that a success. I never lost money selling pot. I am confused – but I am sure that’s the cannabis!

    Reply

Leave a Reply

Your email address will not be published. Required fields are marked *